Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Massis Krekorian"'
Autor:
Massis, Krekorian, Gerwin G W, Sandker, Kimberley R G, Cortenbach, Oya, Tagit, N Koen, van Riessen, René, Raavé, Mangala, Srinivas, Carl G, Figdor, Sandra, Heskamp, Erik H J G, Aarntzen
Publikováno v:
Bioconjugate Chemistry
With the advent of novel immunotherapies, interest in ex vivo autologous cell labeling for in vivo cell tracking has revived. However, current clinically available labeling strategies have several drawbacks, such as release of radiolabel over time an
Autor:
Gerben M. Franssen, Tom W. J. Scheenen, Massis Krekorian, Carl G. Figdor, Erik H.J.G. Aarntzen, Sandra Heskamp, Andor Veltien, Ingrid Jolanda Monique De Vries, Mangala Srinivas, René Raavé, Annemarie Kip, Kimberley R.G. Cortenbach, Nicolaas Koen van Riessen, Milou Boswinkel
Publikováno v:
Cancers, 13, 20
Cancers
Cancers; Volume 13; Issue 20; Pages: 5069
Cancers, Vol 13, Iss 5069, p 5069 (2021)
Cancers, 13
Cancers
Cancers; Volume 13; Issue 20; Pages: 5069
Cancers, Vol 13, Iss 5069, p 5069 (2021)
Cancers, 13
Simple Summary Immune cells are increasingly used for therapy in cancer and other diseases. To better understand immune-cell kinetics, cell-tracking with highly sensitive imaging modalities is required. The aim of this study was to develop a new stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f9be72d4b7d562ecd5a573f79e51cd
https://doi.org/10.3390/cancers13205069
https://doi.org/10.3390/cancers13205069
Autor:
Massis Krekorian, Mangala Srinivas, Oya Tagit, René Raavé, N. Koen van Riessen, Kimberley R.G. Cortenbach, Sandra Heskamp, Erik H.J.G. Aarntzen, Gerwin Sandker, Carl G. Figdor
Publikováno v:
Bioconjugate Chemistry, 32, 8, pp. 1802-1811
Bioconjugate Chemistry, 32, 1802-1811
Bioconjugate Chemistry, 32(8), 1802-1811
Bioconjugate Chemistry 32 (2021) 8
Bioconjugate Chemistry, 32, 1802-1811
Bioconjugate Chemistry, 32(8), 1802-1811
Bioconjugate Chemistry 32 (2021) 8
With the advent of novel immunotherapies, interest in ex vivo autologous cell labeling for in vivo cell tracking has revived. However, current clinically available labeling strategies have several drawbacks, such as release of radiolabel over time an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c744a71b80eed5288afedfd31e72051c
https://doi.org/10.1021/acs.bioconjchem.1c00271
https://doi.org/10.1021/acs.bioconjchem.1c00271
Autor:
Timothy H. Witney, Sandra Heskamp, Gilbert O. Fruhwirth, Carl G. Figdor, Erik H.J.G. Aarntzen, Mangala Srinivas, Massis Krekorian
Publikováno v:
Theranostics, 9, 7924-7947
Theranostics, 9, 25, pp. 7924-7947
Theranostics
Theranostics, 9, 25, pp. 7924-7947
Theranostics
Contains fulltext : 215809.pdf (Publisher’s version ) (Open Access) Immunotherapy has proven to be an effective approach in a growing number of cancers. Despite durable clinical responses achieved with antibodies targeting immune checkpoint molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3acd3666eba1b8cc4063d1b25e65c74
http://hdl.handle.net/2066/215809
http://hdl.handle.net/2066/215809
Autor:
Thomas M. van Gulik, Michal Heger, Allard C. van der Wal, Lindy K. Alles, Gert Storm, Joanne Verheij, Massis Krekorian, Albert C. van Wijk, Claire Mackaaij, Mans Broekgaarden, Ruud Weijer
Publikováno v:
Oncotarget, 7(3), 3341-3356. Impact Journals
Oncotarget
Oncotarget
// Ruud Weijer 1, 2, * , Mans Broekgaarden 1, * , Massis Krekorian 1 , Lindy K. Alles 1 , Albert C. van Wijk 1 , Claire Mackaaij 3 , Joanne Verheij 3 , Allard C. van der Wal 3 , Thomas M. van Gulik 1 , Gert Storm 2, 4 , Michal Heger 1, 4 1 Department
Autor:
Erik H.J.G. Aarntzen, Mangala Srinivas, Alexander H. J. Staal, Massis Krekorian, Gerwin Sandker, Edyta Swider, K. Van Riessen, Sandra Heskamp, Olga Koshkina
Publikováno v:
Nuclear Medicine and Biology. :S42-S43
Autor:
Milan Kos, Thomas M. van Gulik, Michal Heger, Mans Broekgaarden, Ruud Weijer, Albert C. van Wijk, Lindy K. Alles, Zsolt Bikádi, Massis Krekorian, Bas van den IJssel, Eszter Hazai
Publikováno v:
NANO RESEARCH, 9(6), 1639-1662. Press of Tsinghua University
Photodynamic therapy (PDT) is a tumor treatment modality in which a tumorlocalized photosensitizer is excited with light, which results in local production of reactive oxygen species, destruction of tumor vasculature, tumor hypoxia, tumor cell death,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9f86c49e6ef97d4bf46cb590656ad0
https://pure.amc.nl/en/publications/inhibition-of-hypoxiainducible-factor-1-with-acriflavine-sensitizes-hypoxic-tumor-cells-to-photodynamic-therapy-with-zinc-phthalocyanineencapsulating-cationic-liposomes(d7278ad6-138f-4d57-bc3d-60fca0cbd200).html
https://pure.amc.nl/en/publications/inhibition-of-hypoxiainducible-factor-1-with-acriflavine-sensitizes-hypoxic-tumor-cells-to-photodynamic-therapy-with-zinc-phthalocyanineencapsulating-cationic-liposomes(d7278ad6-138f-4d57-bc3d-60fca0cbd200).html
Autor:
JesĂşs Arenas, Maat, Vincent De, CatĂłn, Laura, Massis Krekorian, Herrero, Juan, Ferrara, Flavio, Tommassen, Jan
Primers used in this study. (PDF 256Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5be3b48f59d635d374e09ec000e9a48
Autor:
Michal Heger, Thomas M. van Gulik, Mans Broekgaarden, Ruud Weijer, Milan Kos, Massis Krekorian
Publikováno v:
Free Radical Biology and Medicine. 65:S26-S27
Autor:
Lindy K. Alles, Milan Kos, Mans Broekgaarden, Ruud Weijer, R. Van Vught, T.M. van Gulik, Massis Krekorian, B. Van den IJssel, M. Heger
Publikováno v:
European Journal of Cancer. 50:S205